The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.

A group of European venture capital firms is banding together to try to improve the funding landscape for biotech startups.

Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

Halozyme Therapeutics (HALO) has reportedly spent up to $1.3 billion in acquiring three biotech startups in recent months.

Gotham Biotech’s lease at 6 Main St. in Gray is a straight shot to the highway, an important consideration for overnight shipping of the perishable products. PHOTO / COURTESY COLLIERS OF MAINE A ...

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...

Eli Lilly will acquire Orna Therapeutics for up to $2.4 billion to gain access to the Watertown biotech's circular RNA ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...

First national call is LIVE for new biotech fund under the Centre’s RDI initiative, signalling India’s big bet on Bioeconomy ...

Artificial intelligence and biotech are two of the sectors that have been able to buck the current sluggish pace of venture capital spending. So it’s not surprising a startup at the intersection of ...

Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.

Founders and investors are rethinking exits as companies stay private longer. Early acquisitions and partial sales are ...